Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03953833
What this trial is testing

B003 in Patients With HER2-positive Recurrent or Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Shanghai Pharmaceuticals Holding Co., Ltd 30
Testing effectiveness (Phase 2)UnknownNCT05430347
What this trial is testing

Clinical Study of Pyrotinib in Neoadjuvant Therapy of HR-positive and HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 80
Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)UnknownNCT04158947
What this trial is testing

HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone

Who this might be right for
HER2-positive Breast CancerBrain Metastases
xuexin he 130
Early research (Phase 1)Study completedNCT01423123
What this trial is testing

Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 21
Testing effectiveness (Phase 2)Ended earlyNCT02598310
What this trial is testing

Neoadjuvant Nab-PTX and Trastuzumab for ER Negative and HER2 Positive Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor Negative NeoplasmHER-2 Positive Breast Cancer
Osaka Medical College 30
Testing effectiveness (Phase 2)Study completedNCT01922921
What this trial is testing

Vaccine Therapy With or Without Polysaccharide-K in Patients With Stage IV HER2 Positive Breast Cancer Receiving HER2-Targeted Monoclonal Antibody Therapy

Who this might be right for
HER2/Neu PositiveRecurrent Breast CarcinomaStage IV Breast Cancer
University of Washington 31
Testing effectiveness (Phase 2)Active Not RecruitingNCT04398914
What this trial is testing

Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer

Who this might be right for
Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine 216
Testing effectiveness (Phase 2)Looking for participantsNCT05115474
What this trial is testing

Study of Screening Brain MRIs in Stage IV Breast Cancer

Who this might be right for
Triple Negative Breast CancerHER2-positive Breast CancerHormone Receptor-positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 170
Testing effectiveness (Phase 2)Ended earlyNCT01329640
What this trial is testing

Feasibility Study of Metronomic Chemotherapy for Locally Advanced Her2- Positive Breast Cancer (TraQ-Me 01)

Who this might be right for
Locally Advanced HER2-positive Breast Cancer
Instituto do Cancer do Estado de São Paulo 9
Testing effectiveness (Phase 2)Ended earlyNCT03709082
What this trial is testing

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Who this might be right for
HER2-positive Breast CancerBreast Cancer Metastatic
University of Kansas Medical Center 3
Post-approval studies (Phase 4)UnknownNCT05036005
What this trial is testing

Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON)

Who this might be right for
Breast CancerBreast NeoplasmsBreast Cancer Female+1 more
Institut fuer Frauengesundheit 108
Not applicableLooking for participantsNCT07616440
What this trial is testing

Pilot Study on the Clinical Efficacy of Focused Ultrasound-Mediated Targeted Drug Delivery System Combined With Neoadjuvant Therapy for HER2-Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Second Affiliated Hospital, Zhejiang University, School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT01037790
What this trial is testing

Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With Cancer

Who this might be right for
Adult Solid TumorAdenocarcinoma of the ColonAdenocarcinoma of the Rectum+36 more
Abramson Cancer Center at Penn Medicine 304
Post-approval studies (Phase 4)Looking for participantsNCT06217185
What this trial is testing

The Efficacy and Safety of Pyrotinib, Trastuzumab Combined With Taxanes in the Treatment of Trastuzumab-treated HER2+ Advanced Breast Cancer (ABC).

Who this might be right for
HER2-positive Breast CancerAdvanced Breast Cancer
Hebei Medical University Fourth Hospital 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT01937117
What this trial is testing

Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 88
Early research (Phase 1)Ended earlyNCT02095210
What this trial is testing

HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

Who this might be right for
HER2-positive Breast Cancer
Dorte Nielsen 2
Large-scale testing (Phase 3)UnknownNCT00629278
What this trial is testing

Combination Chemotherapy and Trastuzumab in Treating Women With Stage I, Stage II, or Stage III HER2-Positive Breast Cancer

Who this might be right for
Breast Cancer
Azienda Ospedaliero-Universitaria di Modena 2,500
Not applicableLooking for participantsNCT07030569
What this trial is testing

RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study

Who this might be right for
RadiomicRadiomicsBreast Cancer Metastatic+13 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 500
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824869
What this trial is testing

A Phase II Study of HLX22 in Combination With Trastuzumab and Chemotherapy in HER2-Positive Locally Advanced or Metastatic Breast Cancer Patients

Who this might be right for
HER2 + Breast Cancer
Shanghai Henlius Biotech 90
Next Page